No Data
No Data
Daiichi Sankyo - significant decline, new data on Datopotamab Dulxtecan announced
Significant decline. Regarding datopotamab deruxtecan, new data from phase 3 clinical trials targeting second/third-line treatment for non-small cell lung cancer has been presented at the World Lung Cancer Conference. The results seem to vary in evaluation, but Astrazeneca, its partner, has seen a decline in stock price at the time of data presentation, leading to a sell-off. While there was a tendency of improvement in the median overall survival, which is one of the primary endpoints, compared to the docetaxel administration group, statistically significant improvement was not observed.
Apple has announced the new smart phone series "iPhone16".
[Apple] Apple has announced the new smart phone series "iPhone16". The company's self-developed AI service "Apple Intelligence" will be available on all models. It is rumored that semiconductors designed by Arm Holdings will be used in this new smart phone, causing Arm's stock to rise by more than 7%. <4005> Sumitomo Chemical <5201> AGC <5802> Sumitomo Electric Industries <6440> JUKI <6701> Japan's
The consumer electronics battle is coming! Sony announced that it will hold a press conference on September 10th and may release the PS5 Pro.
①Sony announced that a technical demonstration event will be held at 23:00 on Tuesday, Peking time; ② The speaker is Mark Cerny, the chief architect of the PS5 console, and it is widely expected that this is a sign of the release of the PS5 Pro console; ③ Previous leaks indicate that the graphics rendering capability of the PS5 Pro will be greatly improved, with expectations of a price increase as well.
Reported Saturday, Daiichi Sankyo And Merck's Ifinatamab Deruxtecan Shows Response Rates In Extensive-Stage Small Cell Lung Cancer In Phase 2 IDeate-Lung01 Trial
Former senior official of the Japan Financial Services Agency: There may be another rate hike before the end of the year!
Former senior official Tomoko Amaya of the Japan Ministry of Finance said that the central bank may raise interest rates again before the end of the year; she said that what matters is not the level or volatility of stock prices, but the level of confidence. The stable recovery of the market is enough to make interest rate hikes possible this year.
Selling ahead, but the yen's strength is easing the decline.
The Nikkei average fell for 5 consecutive business days. It ended the trade at 36,215.75 yen, down 175.72 yen (with a volume estimate of 1.8 billion shares). Concerns about the slowdown in the US economy resurfaced following the release of the August US employment statistics on the 6th, causing selling to spread to Japanese stocks. In addition, the yen appreciated temporarily, with the dollar reaching the 141 yen level, which also had an impact. The Nikkei average widened its decline in the mid-morning session and fell to 35,247.87 yen. However, after the yen stopped appreciating, there were buying opportunities and Globex's trade was entered.
Warren Buffed : But cpi is good..n